MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Neurological disease progression in adults with ataxia telangiectasia – a longitudinal study

    AE. Hensiek, L. Bottolo, MY. Tiet, E. Harrison, H. Biggs, E. Ashby, C. Olympio, N. Everett, R. Horvath (Cambridge, United Kingdom)

  • Neurological Wilson’s disease: another form of tauopathies?

    XP. Wang (Shanghai, China)

  • Neuromelanin Loss Is Associated with Increased Substantia Nigra Free-Water: a Longitudinal Study of Controls, RBD, and PD

    V. Madge, K. Wennberg, R. Klevor, A. Dagher, R. Postuma, D L. Collins (Montréal, Canada)

  • Neuromelanin-Sensitive MRI as a Marker of Clinical Severity and Disease Burden in Parkinson’s Disease

    R. Akande, T. Kustermann, S. Holiga, J. Anzures-Cabrera, G. Pagano (Basel, Switzerland)

  • Neuromodulation of Add-on Repetitive Transcranial Magnetic Stimulation improving Freezing of Gait in Parkinson’s Disease: Integrated Cross-sectional and Interventional Evidence

    C. Gan, K. Zhang (Nanjing, China)

  • Neuronal aSynuclein Disease Integrated Staging System (NSD-ISS) Reveals Clinically Meaningful Functional Progression and Quality-of-Life Impact in Parkinson’s Disease

    DA. Olszewska, D. Ghosh, S. Luo, C. Marras (Cork, Ireland)

  • Neurophysiologic Testing Aids Diagnosis of Stiff-person Spectrum Disorders

    J. Bower, F. Ali, L. Jackson, B. Klassen, A. Zekeridou, A. Hassan (ROCHESTER, USA)

  • Neuroprotective and Antiparkinsonian Effects of Green-Synthesized Silver Nanoparticles from Eclipta prostrata in a Haloperidol-Induced Murine Model

    S. Rajput, P. Tiwari, S. Sinha (Delhi, India)

  • Neuroprotective Effects of Curcumin on Hippocampal-PPN Circuitry in a Rotenone-Induced Rat Model of Parkinson’s Disease

    L. Darbinyan, L. Hambardzumyan, L. Manukyan, M. Danielyan, K. Karapetyan, K. Simonyan (Yerevan, Armenia)

  • Neuroprotective Effects of Emodin Against Rotenone-Induced Parkinsonism Through Regulation of SIRT1-Mediated Inflammasome and Nrf2 Pathways

    A. Kumar (Prayagraj, India)

  • « Previous Page
  • 1
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • …
  • 208
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley